Skip to main content
Chronic Respiratory Disease logoLink to Chronic Respiratory Disease
editorial
. 2021 Jan 18;18:1479973120985594. doi: 10.1177/1479973120985594

Spotlight on primary care management of COPD: Electronic health records

Timothy H Harries 1,, Patrick White 1
PMCID: PMC7816527  PMID: 33455426

Long-term management of chronic obstructive pulmonary disease (COPD) in primary care depends on high quality clinical recording. From diagnosis to disease surveillance, it is difficult to assure high quality care of COPD without good records. For some years international evidence has exposed gaps between observed and recommended care in key quality indicators of COPD management including recording in the patient electronic health records (EHRs). This can be seen particularly in the recording and interpretation of spirometry measurements.18 In their recent paper in this journal Heinmüller et al. have highlighted shortcomings in the recording of COPD care in general practices in Germany.9 Their findings suggest sub-optimal care across a range of quality indicators. Spirometry data to confirm a secure diagnosis of COPD could not be extracted. There was a lack of standardized recording within the EHRs. Data were not easily accessible from a single database and the records were difficult to search. It cannot be concluded that poor recording of quality indicators represents genuine deficits in care, but it begs the question whether low quality recording is itself evidence of low quality care.

Poor recording may impede the delivery of appropriate interventions. Absence of records of spirometry-confirmed diagnosis, of smoking history or nicotine replacement therapy, of influenza or pneumococcus vaccination, of referral for pulmonary rehabilitation, or of the occurrence of an exacerbation, may prevent proactive disease surveillance and treatment. Poor recording makes the assessment of quality of care of COPD impossible in both the individual and in the practice overall. Comprehensive record-keeping provides a baseline against which change can be judged. Improvements in the recording of care may not assure improvements in the quality of care, but they are essential to the assessment of quality. Rates of recording of spirometry in COPD patients in primary care vary greatly across different countries and are often low.5,6,911 Where spirometry is recorded interpretation is frequently inaccurate with up to 30% of patients incorrectly diagnosed with COPD.58,10,11 Rothnie et al. found that 99% of primary care traces were of adequate quality but that only 73% were consistent with obstruction.5 Concerted efforts such as the adoption of a national program in Finland for the prevention and treatment of COPD in primary care and the Quality and Outcomes Framework (QOF) in the United Kingdom (UK) have been associated with significant improvements in the recording of patient smoking habits and spirometry results in the EHRs.11,12 The maintenance of a COPD diagnostic disease register may also be associated with higher rates of recording of quality indicators.10

In addition to seeking improvements in the recording of care, the Disease Management Program (DMP) for COPD care in Germany aims to enhance the quality of care through a “top down” system.9 This approach has led to increased adherence to treatment guidelines in primary care but as yet it has not been associated with reduced rates of hospital admissions for COPD exacerbations.13,14 In the National Health Service (NHS) in England approximately 95% of general practices participate in the QOF.15 The QOF is also a “top down” system of financial incentives for general practices to standardize and improve their care of patients with long-term medical conditions, including COPD.16 Electronic prompts can be integrated in the EHR to remind clinicians of the need to collect data during a consultation in order to meet the QOF criteria. Although a pay-for-performance approach may improve the recording of care in general practice, its effects on quality of care are far from clear.17 In addition, the beneficial effects of pay-for-performance care may be short-term.18 The use of financial incentives has been criticized for eroding professional autonomy and for diverting clinical focus to those aspects of care which are measurable at the expense of other facets of care including the patient’s concerns during the consultation.17,19 Better recording may be achieved in the context of a system like the QOF. It does not inevitably lead to better care, but without good quality recording high quality care is much harder to deliver in general practice.

Reliable EHR recording in COPD care is of importance to the possible prevention of exacerbations, an important cause of worse prognosis in COPD.20 The previous history of exacerbations is a key criterion in prescribing, especially of inhaled corticosteroid (ICS) therapy, to prevent acute exacerbations.21,22 It is difficult to assess accurately the frequency of COPD exacerbations due to their subjective nature and variation in their recording in the EHR.23 Accessing data on exacerbations from EHRs can be complicated and time-consuming and the practice and accuracy of coding in primary care varies widely between individual clinicians.24 Data on exacerbations often are entered in a free-text format and can only be retrieved by inspection of individual patient records, undermining the reliability of large-scale data searches.25 Only those episodes recorded with an accepted electronic code will be detected during an EHR search. One way of identifying an exacerbation is by the prescription of antibiotics and oral corticosteroids.5 These are frequently prescribed to patients in advance as “rescue packs” to enable COPD patients to intervene early in an exacerbation, reduce its severity and prevent hospital admission.26 The widespread community prescribing of these packs, for which there is sparse evidence of effectiveness,27 without evidence of the exacerbation for which they were prescribed, impedes the accurate assessment of the prevalence of moderate COPD exacerbations. Improvements in data recording and auditing of COPD care in UK general practice has occurred during a time of rising rates of prescription of inhaled drugs, including ICS therapy.26 The change has not been associated with improvements in exacerbation-related hospital admissions or readmissions.26,28

Long-term surveillance and acute decision making in COPD require good EHR recording in primary care. Annual reviews of COPD should be informed by past records of smoking history and cessation treatment, vaccination, and referral for pulmonary rehabilitation. Consistent recording of exacerbation history is essential to targeted prescribing to prevent acute exacerbations. Reliable and complete recording should be an essential element of high quality COPD care. Without it, doubts arise about the accuracy of the diagnosis, and systematic long-term management of COPD becomes very difficult.

Footnotes

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article.

References

  • 1. Arne M, Lisspers K, Ställberg B, et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med 2010; 104: 550–556. [DOI] [PubMed] [Google Scholar]
  • 2. Ragaišienė G, Kibarskytė R, Gauronskaitė R, et al. Diagnosing COPD in primary care: what has real life practice got to do with guidelines? Multidiscip Respir Med 2019; 14: 28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Steurer-Stey C, Dallalana K, Jungi M, et al. Management of chronic obstructive pulmonary disease in Swiss primary care: room for improvement. Qual Prim Care 2012; 20: 365–373. [PubMed] [Google Scholar]
  • 4. Casas Herrera A, Montes de Oca M, López Varela MV, et al. COPD underdiagnosis and misdiagnosis in a high-risk primary care population in four Latin American countries. A key to enhance disease diagnosis: the PUMA study. PloS One 2016; 11: e0152266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Rothnie KJ, Chandan JS, Goss HG, et al. Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care. Int J Chron Obstruct Pulmon Dis 2017; 12: 1663–1668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. van de Hei SJ, Flokstra-de Blok BM, Baretta HJ, et al. Quality of spirometry and related diagnosis in primary care with a focus on clinical use. NPJ Prim Care Respir Med 2020; 30: 22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. White P, Wong W, Fleming T, et al. Primary care spirometry: test quality and the feasibility and usefulness of specialist reporting. Br J Gen Pract J R Coll Gen Pract 2007; 57: 701–705. [PMC free article] [PubMed] [Google Scholar]
  • 8. Tollånes MC, Sjaastad GE, Aarli BB, et al. Spirometry in chronic obstructive pulmonary disease in Norwegian general practice. BMC Fam Pract 2020; 21: 235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Heinmüller S, Schaubroeck E, Frank L, et al. The quality of COPD care in German general practice—a cross-sectional study. Chron Respir Dis 2020; 17: 1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Jones RC, Dickson-Spillmann M, Mather MJ, et al. Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit. Respir Res 2008; 9: 62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Vasankari T, Pietinalho A, Lertola K, et al. Use of spirometry and recording of smoking habits of COPD patients increased in primary health care during national COPD programme. BMC Fam Pract 2011; 12: 97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Taggar JS, Coleman T, Lewis S, et al. The impact of the Quality and Outcomes Framework (QOF) on the recording of smoking targets in primary care medical records: cross-sectional analyses from the Health Improvement Network (THIN) database. BMC Public Health 2012; 12: 329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Mehring M, Donnachie E, Fexer J, et al. Disease management programs for patients with COPD in Germany: a longitudinal evaluation of routinely collected patient records. Respir Care 2014; 59: 1123–1132. [DOI] [PubMed] [Google Scholar]
  • 14. Achelrod D, Welte T, Schreyögg J, et al. Costs and outcomes of the German disease management programme (DMP) for chronic obstructive pulmonary disease (COPD)—a large population-based cohort study. Health Policy Amst Neth 2016; 120: 1029–1039. [DOI] [PubMed] [Google Scholar]
  • 15. NHS Digital. Quality and Outcomes Framework, achievement, prevalence and exceptions data 2018–19. https://digital.nhs.uk/data-and-information/publications/statistical/quality-and-outcomes-framework-achievement-prevalence-and-exceptions-data/2018-19-pas (2019, accessed 11 September 2020). [Google Scholar]
  • 16. Roland M. Linking physicians’ pay to the quality of care—a major experiment in the United Kingdom. N Engl J Med 2004; 351: 1448–1454. [DOI] [PubMed] [Google Scholar]
  • 17. Roland M, Campbell S. Successes and failures of pay for performance in the United Kingdom. N Engl J Med 2014; 370: 1944–1949. [DOI] [PubMed] [Google Scholar]
  • 18. Roland M, Guthrie B. Quality and Outcomes Framework: what have we learnt? BMJ 2016; 354: i4060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Scott A, Sivey P, Ouakrim DA, et al. The effect of financial incentives on the quality of health care provided by primary care physicians. Cochrane Database Syst Rev 2011; 9: CD008451 DOI: 10.1002/14651858.CD008451.pub2. [DOI] [PubMed] [Google Scholar]
  • 20. Rothnie KJ, Müllerová H, Smeeth L, et al. Natural history of chronic obstructive pulmonary disease exacerbations in a general practice-based population with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2018; 198: 464–471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Harries TH, Rowland V, Corrigan CJ, et al. Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis. Respir Res 2020; 21: 3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD Science Committee Report 2019. Eur Respir J 2019; 53: 1–12. [DOI] [PubMed] [Google Scholar]
  • 23. Harries TH, Gilworth G, Corrigan CJ, et al. Inhaled corticosteroids prescribed for COPD patients with mild or moderate airflow limitation: who warrants a trial of withdrawal? Int J Chron Obstruct Pulmon Dis 2019; 14: 3063–3066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Majeed A, Car J, Sheikh A. Accuracy and completeness of electronic patient records in primary care. Fam Pract 2008; 25: 213–214. [DOI] [PubMed] [Google Scholar]
  • 25. Bradley SH, Lawrence NR, Carder P. Using primary care data for health research in England—an overview. Future Healthc J 2018; 5: 207–212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Harries TH, Seed PT, Jones S, et al. Chronic obstructive pulmonary disease hospital admissions and drugs—unexpected positive associations: a retrospective general practice cohort study. NPJ Prim Care Respir Med 2014; 24: 14006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Thompson WH, Nielson CP, Carvalho P, et al. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996; 154: 407–412. [DOI] [PubMed] [Google Scholar]
  • 28. Harries TH, Thornton H, Crichton S, et al. Hospital readmissions for COPD: a retrospective longitudinal study. NPJ Prim Care Respir Med 2017; 27: 31. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Chronic Respiratory Disease are provided here courtesy of SAGE Publications

RESOURCES